the market?
ResMed, Inc.
NYSE: RMD
50.08
0.10
(0.20%)
| Today's Open | $49.76 |
|---|---|
| Previous Close | $49.98 |
| Daily Range | $49.59 - $50.23 |
| 52-Week Range | $29.82 - $51.40 |
| Market Cap | $7.1B |
| P/E Ratio | 23.46 |
| Dividend (Yield) | $0.68 (1.4%) |
| Ex-Dividend Date Dividend Pay Date |
05/17/13 06/18/13 |
| Volume | 540,694 |
| Average Daily Volume | 1,026,124 |
| Current FY EPS | $2.25 |
How do you think RMD
will perform against the market?
Top RMD Bull/Bear Pitches
tmeri (< 20)
Submitted
March 5, 2011
Because their strongest competitor, Respironics, has been bought by another company.
1simplemind (< 20)
Submitted
November 29, 2007
I am a Medicare provider of ResMed's line of products and have done so for the past 8 years. Medicare and the other insurers are shrinking the reimbursements to providers of this product (me) as the … More
News & Commentary
ResMed Beats Analyst Estimates on EPS
Just the facts, Fool.X Factor: 5 Stocks Reaching Their Ex-Dividend Date on May 17
PBF Energy, AEGON, and Microchip Technology are on the list.How ResMed is Bringing Bucks Home More Quickly
Don't just count the cash, time it.Sector
Healthcare
Industry
Healthcare Information Services
ResMed, Inc. (RMD) Description
The Company is a developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. Website: http://www.resmed.com.au/
CEO Rating by Glassdoor
More details for ResMed Jobs
ResMed reviews from employees
